These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2223 related articles for article (PubMed ID: 7954938)

  • 1. Synthetic dipeptide, N-stearoyl-D-Ser-L-Pro-OEt, induces release of tissue-type plasminogen activator in cultured cells and in experimental animals.
    Okayama T; Nakano M; Odake S; Hagiwara M; Morikawa T; Ueshima S; Okada K; Fukao H; Matsuo O
    Chem Pharm Bull (Tokyo); 1994 Sep; 42(9):1854-8. PubMed ID: 7954938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivatives of melphalan designed to enhance drug accumulation in cancer cells.
    Kupczyk-Subotkowska L; Tamura K; Pal D; Sakaeda T; Siahaan TJ; Stella VJ; Borchardt RT
    J Drug Target; 1997; 4(6):359-70. PubMed ID: 9239576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid and strong increase of plasminogen activator induced by experimental anaphylaxis in rabbits.
    Shimaya K; Sumi H; Maruyama M; Mihara H
    Enzyme; 1992; 46(4-5):204-12. PubMed ID: 1292930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain.
    Stack MS; Gray RD; Pizzo SV
    Cancer Res; 1993 May; 53(9):1998-2004. PubMed ID: 8481902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human tissue-type plasminogen activator variants with amino acid mutations in the kringle 1 domain.
    Ikenaka Y; Yajima K; Yahara H; Maruyama H; Matsumoto K; Okada K; Ueshima S; Matsuo O
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):381-7. PubMed ID: 1330023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of N-glycosylation on in vitro activity of Bowes melanoma and human colon fibroblast derived tissue plasminogen activator.
    Wittwer AJ; Howard SC; Carr LS; Harakas NK; Feder J; Parekh RB; Rudd PM; Dwek RA; Rademacher TW
    Biochemistry; 1989 Sep; 28(19):7662-9. PubMed ID: 2514792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
    van Giezen JJ; Boon GI; Jansen JW; Bouma BN
    Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity and translocation relationships via hPEPT1 of H-X aa-Ser-OH dipeptides: evaluation of H-Phe-Ser-OH as a pro-moiety for ibuprofen and benzoic acid prodrugs.
    Omkvist DH; Trangbæk DJ; Mildon J; Paine JS; Brodin B; Begtrup M; Nielsen CU
    Eur J Pharm Biopharm; 2011 Feb; 77(2):327-31. PubMed ID: 21147219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man.
    Newby DE; Wright RA; Dawson P; Ludlam CA; Boon NA; Fox KA; Webb DJ
    Cardiovasc Res; 1998 May; 38(2):485-92. PubMed ID: 9709410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.
    Peraldi MN; Rondeau E; Medcalf RL; Hagège J; Lacave R; Delarue F; Schleuning WD; Sraer JD
    Biochim Biophys Acta; 1992 Apr; 1134(3):189-96. PubMed ID: 1558843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
    Lucore CL; Fujii S; Sobel BE
    Circulation; 1989 Jun; 79(6):1204-13. PubMed ID: 2498004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.
    Kouemo S; McMillan E; Doctor V
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):425-30. PubMed ID: 20445443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of chronic epaden administration on the tissue plasminogen activator activity in rabbits].
    Petrukhina GN; Kalugin SA; Makarov VA; Gandel' VG
    Eksp Klin Farmakol; 2000; 63(6):30-3. PubMed ID: 11202508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo.
    Goglia L; Tosi V; Sanchez AM; Flamini MI; Fu XD; Zullino S; Genazzani AR; Simoncini T
    Mol Hum Reprod; 2010 Oct; 16(10):761-9. PubMed ID: 20547636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
    Collen D; Lu HR; Lijnen HR; Nelles L; Stassen JM
    Circulation; 1991 Sep; 84(3):1216-34. PubMed ID: 1909220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin enhances release of tissue plasminogen activator from bovine corneal endothelial cells.
    Fukushima M; Nakashima Y; Sueishi K
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1576-83. PubMed ID: 2501229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of thrombi with tissue-type plasminogen activator rendered enzymatically inactive and conjugated to a residualizing label.
    Ord JM; Hasapes J; Daugherty A; Thorpe SR; Bergmann SR; Sobel BE
    Circulation; 1992 Jan; 85(1):288-97. PubMed ID: 1728459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
    Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
    Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 112.